Journal
MOLECULAR ASPECTS OF MEDICINE
Volume 45, Issue -, Pages 37-46Publisher
ELSEVIER
DOI: 10.1016/j.mam.2015.05.003
Keywords
Prostate cancer; Biomarker; RNA; Non-coding; RNA; IncRNA; Gene signatures
Funding
- NCI Cancer Center Support Grant [P30CA138292]
- NIH [U01CA113913]
Ask authors/readers for more resources
A large number of men are diagnosed with prostate cancer each year, but many will not experience morbidity or mortality as a result of their cancers. Therefore, biomarkers for prostate cancer are necessary to carefully select patients for initial diagnostic biopsy or to facilitate care decisions for men who have already been diagnosed with prostate cancer. RNA-based approaches to biomarker discovery allow the investigation of non-coding RNAs, gene fusion transcripts, splice variants, and multi-gene expression panels in tissue, urine, or blood as opportunities to improve care decisions. This review focuses on RNA biomarkers that are available as commercial assays, and therefore already available for potential clinical use, as well as providing an overview of newer RNA biomarkers that are in earlier stages of clinical development. (C) 2015 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available